Mitochondria Clumping vs. Mitochondria Fusion in CMT2A Diseases
Phenotypic variations in Charcot-Marie-Tooth disease type 2A (CMT2A) result from the many mutations in the mitochondrial fusion protein, mitofusin 2 (MFN2). While the GTPase domain mutations of MFN2 lack the ability to hydrolyze GTP and complete mitochondrial fusion, the mechanism of dysfunction in...
Main Authors: | Antonietta Franco, Caroline E. Walton, Xiawei Dang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/12/2110 |
Similar Items
-
Piperine Derivatives Enhance Fusion and Axonal Transport of Mitochondria by Activating Mitofusins
by: Lihong Zhang, et al.
Published: (2022-06-01) -
CMT2A Harboring Mitofusin 2 Mutation with Optic Nerve Atrophy and Normal Visual Acuity
by: Guerriero S, et al.
Published: (2020-02-01) -
Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A
by: Antonietta Franco, et al.
Published: (2020-10-01) -
Autophagy and proliferation are dysregulated in Charcot-Marie-Tooth disease type 2A cells harboring MFN2 (mitofusin 2) mutation
by: Paola Zanfardino, et al.
Published: (2022-12-01) -
Differential effects of Mendelian GDAP1 clinical variants on mitochondria-lysosome membrane contacts sites
by: Lara Cantarero, et al.
Published: (2023-04-01)